Mirtazapine (Hemihydrate) - Advanced Medical Drug for Major Depressive Disorder
Discover the exceptional effectiveness of Mirtazapine Hemihydrate, an advanced pharmaceutical-grade medication designed to provide comprehensive treatment for Major Depressive Disorder (MDD). This top-tiered product is formulated to combat severe depressive symptoms, enhance mood, and reinvigorate interest in regular activities, significantly improving the overall quality of life.
Key Features:
- Premium-quality controlled medication for MDD
- Expertly formulated for maximum efficacy
- Effective in combating severe depressive symptoms
- Enhances mood and reinvigorates interest in regular activities
- Improves the overall quality of life
- Synonyms: Remeron, Avanza, Zispin
- IUPAC Name: 2-methyl-1,2,3,4,10,14b-hexahydro-2H-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine hemihydrate
- CAS Number: 61337-67-5 (Hydrate)
- Molecular Formula: C17H19N3u2022(1/2)H2O
- Molecular Weight: 265.36 g/mol (Hydrate)
- Canonical SMILES: CN1CCN2C(C1)C3=CC=CC=C3CC=C2O
- pH: Forms a stable solution at pH 6-7, suitable for consumption
- Hazard and Precautionary Statements: H315-H319-H335. May cause skin, eye, and respiratory irritation
- LD50: 253mg/kg (Oral, Rat)
- Routes of Exposure: Safe for oral administration
- Pharmacological Class: Potent antidepressant
- Mechanism of Action: Amplifies neural activity of norepinephrine and serotonin neurotransmitters within the brain
- Therapeutic Uses: Alleviates anxiety and sleep disorders in addition to treating MDD
- Dosage: Consumption highly recommended under healthcare professional supervision
- Side Effects: Monitor for signs like increased appetite, weight gain, and drowsiness
- Drug Interactions: Caution advised when combined with Monoamine Oxidase Inhibitors (MAOIs) or Selective Serotonin Reuptake Inhibitors (SSRIs)
- Securely packaged in 25kg drums for preservation of high quality during transit
- Flexible production capacity ensuring robust position in the global market